Conjunctivitis or episcleritis and scleritis comprised the most common eye manifestations, while cataracts (11.7%) and visual ...

SAN CARLOS, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the U.S. Food and Drug Administration (FDA) has approved TAVNEOS (avacopan), an orally ...

For remission induction, dose reduction and avoidance of prolonged use of cyclophosphamide have been successfully implemented; the addition of plasma exchange has increased the rate of renal recovery ...

Risk factors for relapse after reinduction treatment with rituximab in patients with antineutrophil cytoplasmic ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Despite advances in biologic therapies, “excess steroid use” remains a mainstay of treatment for ...

A data-driven subclassification of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis has identified five distinct clusters with varying degrees of kidney involvement and systemic ...

Cigarette smoking was associated with ANCA-associated vasculitis, particularly myeloperoxidase ANCA-positive vasculitis, according to data published in JAMA Internal Medicine. “We have an incomplete ...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, ANCA Vasculitis pipeline constitutes 12+ key companies continuously working towards developing 12+ ANCA Vasculitis ...

Mycophenolate mofetil (CellCept) was as effective as cyclophosphamide for remission induction in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, Japanese researchers reported. In a ...

Wegener's granulomatosis, microscopic polyangiitis (MPA), Churg–Strauss syndrome, and primary pauci-immune crescentic glomerulonephritis are associated with circulating anti-neutrophil cytoplasmic ...

Credit: Getty Images Men have higher serum creatinine levels at presentation and are more likely to start dialysis within 4 weeks of diagnosis compared with women. PHILADELPHIA—Investigators who ...